Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Quantification of Tumor Oxygenation Based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference Region.

Lazzeroni M, Toma-Dasu I, Ureba A, Schiavo F, Wiedenmann N, Bunea H, Thomann B, Baltas D, Mix M, Stoykow C, Sörensen A, Grosu AL.

Adv Exp Med Biol. 2020;1232:177-182. doi: 10.1007/978-3-030-34461-0_22.

PMID:
31893408
2.

Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy-results from a prospective trial.

Nicolay NH, Wiedenmann N, Mix M, Weber WA, Werner M, Grosu AL, Kayser G.

Eur J Nucl Med Mol Imaging. 2019 Dec 7. doi: 10.1007/s00259-019-04598-9. [Epub ahead of print]

PMID:
31811344
3.

Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy.

Sörensen A, Carles M, Bunea H, Majerus L, Stoykow C, Nicolay NH, Wiedenmann NE, Vaupel P, Meyer PT, Grosu AL, Mix M.

Eur J Nucl Med Mol Imaging. 2019 Nov 26. doi: 10.1007/s00259-019-04609-9. [Epub ahead of print]

PMID:
31773233
4.

Automatic Tumor Segmentation With a Convolutional Neural Network in Multiparametric MRI: Influence of Distortion Correction.

Bielak L, Wiedenmann N, Nicolay NH, Lottner T, Fischer J, Bunea H, Grosu AL, Bock M.

Tomography. 2019 Sep;5(3):292-299. doi: 10.18383/j.tom.2019.00010.

5.

Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.

Wiedenmann N, Bunea H, Rischke HC, Bunea A, Majerus L, Bielak L, Protopopov A, Ludwig U, Büchert M, Stoykow C, Nicolay NH, Weber WA, Mix M, Meyer PT, Hennig J, Bock M, Grosu AL.

Radiat Oncol. 2018 Sep 21;13(1):183. doi: 10.1186/s13014-018-1134-7.

6.

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.

Wiedenmann N, Bunea H, Rischke HC, Bunea A, Majerus L, Bielak L, Protopopov A, Ludwig U, Büchert M, Stoykow C, Nicolay NH, Weber WA, Mix M, Meyer PT, Hennig J, Bock M, Grosu AL.

Radiat Oncol. 2018 Aug 29;13(1):159. doi: 10.1186/s13014-018-1103-1. Erratum in: Radiat Oncol. 2018 Sep 21;13(1):183.

7.

Biological imaging for individualized therapy in radiation oncology: part II medical and clinical aspects.

Gkika E, Oehlke O, Bunea H, Wiedenmann N, Adebahr S, Nestle U, Zamboglou C, Kirste S, Fennell J, Brunner T, Gainey M, Baltas D, Langer M, Urbach H, Bock M, Meyer PT, Grosu AL.

Future Oncol. 2018 Apr;14(8):751-769. doi: 10.2217/fon-2017-0465. Epub 2018 Mar 9.

PMID:
29521519
8.

Using a contextualized sensemaking model for interaction design: A case study of tumor contouring.

Aselmaa A, van Herk M, Laprie A, Nestle U, Götz I, Wiedenmann N, Schimek-Jasch T, Picaud F, Syrykh C, Cagetti LV, Jolnerovski M, Song Y, Goossens RH.

J Biomed Inform. 2017 Jan;65:145-158. doi: 10.1016/j.jbi.2016.12.001. Epub 2016 Dec 5.

9.

Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.

Bittner MI, Wiedenmann N, Bucher S, Hentschel M, Mix M, Rücker G, Weber WA, Meyer PT, Werner M, Grosu AL, Kayser G.

Acta Oncol. 2016 Nov;55(11):1299-1304. Epub 2016 Sep 3.

PMID:
27593107
10.

Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome.

Wiedenmann NE, Bucher S, Hentschel M, Mix M, Vach W, Bittner MI, Nestle U, Pfeiffer J, Weber WA, Grosu AL.

Radiother Oncol. 2015 Oct;117(1):113-7. doi: 10.1016/j.radonc.2015.09.015. Epub 2015 Sep 29.

PMID:
26432067
11.

Clipping of tumour resection margins allows accurate target volume delineation in head and neck cancer adjuvant radiation therapy.

Bittermann G, Wiedenmann N, Bunea A, Schwarz SJ, Grosu AL, Schmelzeisen R, Metzger MC.

Radiother Oncol. 2015 Jul;116(1):82-6. doi: 10.1016/j.radonc.2015.04.025. Epub 2015 May 14.

PMID:
25981050
12.

Marking of tumor resection borders for improved radiation planning facilitates reduction of radiation dose to free flap reconstruction in head and neck cancer surgery.

Bittermann G, Wiedenmann N, Voss P, Zimmerer R, Duttenhoefer F, Metzger MC.

J Craniomaxillofac Surg. 2015 May;43(4):567-73. doi: 10.1016/j.jcms.2015.02.021. Epub 2015 Mar 10.

PMID:
25841307
13.

Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.

Combs SE, Engelhard C, Kopp C, Wiedenmann N, Schramm O, Prokic V, Debus J, Molls M, Grosu AL.

Radiother Oncol. 2015 Mar;114(3):378-83. doi: 10.1016/j.radonc.2015.01.011. Epub 2015 Feb 20.

PMID:
25702864
14.

FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results.

Bilger A, Bittner MI, Grosu AL, Wiedenmann N, Meyer PT, Firat E, Niedermann G, Weber WA, Milanović D.

Strahlenther Onkol. 2014 Oct;190(10):957-61. doi: 10.1007/s00066-014-0693-2. Epub 2014 Jun 14.

PMID:
24928248
15.

Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy.

Bittner MI, Wiedenmann N, Bucher S, Hentschel M, Mix M, Weber WA, Grosu AL.

Radiother Oncol. 2013 Sep;108(3):511-6. doi: 10.1016/j.radonc.2013.06.012. Epub 2013 Jul 10.

PMID:
23849686
16.

Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.

Prokic V, Wiedenmann N, Fels F, Schmucker M, Nieder C, Grosu AL.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):264-70. doi: 10.1016/j.ijrobp.2012.02.036. Epub 2012 Apr 18.

PMID:
22516808
17.

An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.

Grosu AL, Astner ST, Riedel E, Nieder C, Wiedenmann N, Heinemann F, Schwaiger M, Molls M, Wester HJ, Weber WA.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1049-58. doi: 10.1016/j.ijrobp.2010.07.002. Epub 2011 May 11.

PMID:
21570201
18.

Radiation therapy plus angiogenesis inhibition with bevacizumab: rationale and initial experience.

Nieder C, Wiedenmann N, Andratschke NH, Astner ST, Molls M.

Rev Recent Clin Trials. 2007 Sep;2(3):163-8. Review.

PMID:
18474001
19.

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.

Grosu AL, Souvatzoglou M, Röper B, Dobritz M, Wiedenmann N, Jacob V, Wester HJ, Reischl G, Machulla HJ, Schwaiger M, Molls M, Piert M.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):541-51.

PMID:
17869667
20.

Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.

Wiedenmann N, Koto M, Raju U, Milas L, Mason KA.

Invest New Drugs. 2007 Oct;25(5):411-6. Epub 2007 May 11.

PMID:
17492397
21.

130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.

Wiedenmann N, Valdecanas D, Hunter N, Hyde S, Buchholz TA, Milas L, Mason KA.

Clin Cancer Res. 2007 Mar 15;13(6):1868-74.

22.

Current status of angiogenesis inhibitors combined with radiation therapy.

Nieder C, Wiedenmann N, Andratschke N, Molls M.

Cancer Treat Rev. 2006 Aug;32(5):348-64. Epub 2006 May 19. Review.

PMID:
16713103
23.

Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunction.

Andratschke N, Schnaiter A, Weber WA, Cai L, Schill S, Wiedenmann N, Schwaiger M, Molls M, Nieder C.

Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1513-8. Erratum in: Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):960. Schnaitera, Andrea [corrected to Schnaiter, Andrea]; Caia, Lu [corrected to Cai, Lu].

PMID:
16580501
24.

Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model.

Ljungkvist AS, Bussink J, Kaanders JH, Wiedenmann NE, Vlasman R, van der Kogel AJ.

Radiat Res. 2006 Mar;165(3):326-36.

PMID:
16494521
25.

Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumors.

Nieder C, Grosu AL, Stark S, Wiedenmann N, Busch R, Kneschaurek P, Molls M.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1055-9. Epub 2005 Dec 9.

PMID:
16338100
26.

Biological imaging in radiation oncology.

Grosu AL, Wiedenmann N, Molls M.

Z Med Phys. 2005;15(3):141-5.

PMID:
16171034
27.

Prevention of radiation-induced central nervous system toxicity: a role for amifostine?

Nieder C, Andratschke NH, Wiedenmann N, Molls M.

Anticancer Res. 2004 Nov-Dec;24(6):3803-9. Review.

28.

Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?

Nieder C, Andratschke N, Wiedenmann N, Busch R, Grosu AL, Molls M.

Strahlenther Onkol. 2004 Jul;180(7):401-7. Review.

PMID:
15241527
29.

Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience.

Grosu AL, Lachner R, Wiedenmann N, Stärk S, Thamm R, Kneschaurek P, Schwaiger M, Molls M, Weber WA.

Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1450-63.

PMID:
12873691

Supplemental Content

Loading ...
Support Center